Original Research
Accepted on 16 Feb 2026
A Decade of Esophageal Cancer in Kazakhstan: What the National Cancer Registry Reveals (2014–2023)
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Type at least 3 characters
1,157 articles
articles
Original Research
Accepted on 16 Feb 2026
Trends and Disparities in Bone Cancer Mortality Among US Adults from 1999 to 2020: A Joinpoint Regression Analysis Based on the CDC WONDER Database
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Editorial
Accepted on 10 Feb 2026
Editorial: Resistance Training for The Oncology Patient
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Accepted on 09 Feb 2026
Patients' Knowledge, Attitudes, Preferences Regarding Kidney Cancer Screening, and Factors Influencing Participation Intentions: A Qualitative Study
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Accepted on 09 Feb 2026
Association of ZIP Code Sociodemographic Characteristics with Radiation Oncology Services, Payments, and Technique Utilization
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Published on 09 Feb 2026
Guideline-concordant cancer screening among Deaf, DeafBlind, and Hard of Hearing (DDBHH) Puerto Ricans who use American Sign Language
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1771970
- 605 views
Original Research
Accepted on 06 Feb 2026
Influence of COVID-19 Pandemic on Colon Cancer Presentations
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Accepted on 05 Feb 2026
Impact of Biliary Fungal Contamination on Outcomes after Pancreaticoduodenectomy for Pancreatic Cancer
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Published on 05 Feb 2026
The expression pattern and prognostic relevance of p120-catenin, COL4A2 and SOX10 in glioma
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1769786
- 469 views
Original Research
Published on 05 Feb 2026
Development and validation of simplified prognostic models for 14- and 30-day mortality in advanced cancer: beyond the glasgow prognostic score
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1729131
- 475 views
Review
Accepted on 03 Feb 2026
Hepatitis B Virus, Alcohol, and Liver Cancer
in Cancer Epidemiology and Prevention
Frontiers in Oncology
- 343 views
Correction
Accepted on 03 Feb 2026
Corrigendum: A differential process mining analysis of COVID-19 management for cancer patients
in Cancer Epidemiology and Prevention
Frontiers in Oncology
- 113 views
Original Research
Accepted on 03 Feb 2026
Survival Outcomes and Relapse Patterns in High-Risk Metastatic Neuroblastoma Treated with Radiotherapy-Only Consolidation in a Resource-Limited Setting: A Retrospective Study from a Lower-Middle-Income Country
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Accepted on 02 Feb 2026
Global Burden of Thyroid Cancer in Males: A Comprehensive Analysis of Incidence, Mortality, and Risk Factors from 1990 to 2040
in Cancer Epidemiology and Prevention
Frontiers in Oncology
- 129 views
Original Research
Accepted on 02 Feb 2026
Screening children and adolescents for cutaneous malignant melanoma: the impossible trade-off between life-years saved and unnecessary biopsies
in Cancer Epidemiology and Prevention
Frontiers in Oncology
Original Research
Published on 02 Feb 2026
Artificial intelligence driven multi-omics framework identifies COL6A3 as a diagnostic biomarker and a putative gene target modulated by Embelin in Colorectal cancer
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1711079
- 673 views
Original Research
Published on 02 Feb 2026
From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancer
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2025.1730423
- 453 views
Original Research
Accepted on 30 Jan 2026
Equity and Representation in Oncology Clinical Evidence for FDA-Approved Treatments
in Cancer Epidemiology and Prevention
Frontiers in Oncology
- 161 views
Original Research
Accepted on 30 Jan 2026
Combined Assessment of ERO1A Expression and CD163+ Tumor-Associated Macrophage Infiltration is Superior to Traditional Assessment Methods in Predicting Clear Cell Renal Cell Carcinoma Prognosis
in Cancer Epidemiology and Prevention
Frontiers in Oncology
- 192 views
Systematic Review
Published on 30 Jan 2026
Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1740352
- 682 views
Correction
Published on 28 Jan 2026
Correction: Epidemiological profile of patients with malignant neoplasm admitted to a tertiary care center in India: a retrospective cross-sectional study
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1783850
- 376 views
Original Research
Published on 27 Jan 2026
Global, regional, and national burden of liver cancer attributable to high BMI, 1990-2021, with future projections to 2040
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2025.1630875
- 602 views
Original Research
Published on 26 Jan 2026
Inpatient burden of lung cancer and changes after a hospital performance reform: a real-world study
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2025.1771441
- 608 views
Systematic Review
Published on 26 Jan 2026
Suicide risk and mortality among patients with cancers of the digestive system: a systematic review and meta-analysis
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2026.1655968
- 744 views